Last update 08 May 2025

JCAR-020

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Anti MUC-16 chimeric antigen receptor T-cell therapy, Anti-MUC16 CAR-T cell therapy, IL-12-secreting MUC-16 CAR-T cell therapy
+ [6]
Target
IL-12 x MUC16
Action
inhibitors
Mechanism
IL-12 inhibitors(Interleukin-12 inhibitors), MUC16 inhibitors(Mucin-16 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication
Ovarian Cancer
Inactive Indication
Peritoneal Neoplasms
Originator Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Active Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Inactive Organization
Juno Therapeutics, Inc.Juno Therapeutics, Inc.Eureka Therapeutics, Inc.Eureka Therapeutics, Inc.
License Organization
Juno Therapeutics, Inc.Juno Therapeutics, Inc.Eureka Therapeutics, Inc.Eureka Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with JCAR-020
Login to view more data
100 Translational Medicine associated with JCAR-020
Login to view more data
100 Patents (Medical) associated with JCAR-020
Login to view more data
100 Deals associated with JCAR-020
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peritoneal NeoplasmsPhase 1
United States
Eureka Therapeutics, Inc.Eureka Therapeutics, Inc.
01 Apr 2018
Ovarian CancerPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free